A growing body of evidence suggests the involvement of inflammatory processes in the pathophysiology of schizophrenia. Four-to 8-week exposure to cuprizone, a copper chelator, causes robust demyelination and has been used to build a model for multiple sclerosis. In contrast, we report here the effects of 1-week cuprizone exposure in mice. This short-term cuprizone exposure elicits behavioral changes that include augmented responsiveness to methamphetamine and phencyclidine, as well as impaired working memory. The cellular effects of 1-week cuprizone exposure differ substantially from the longer-term exposure; perturbation of astrocytes and microglia is induced without any sign of demyelination. Furthermore, the proinflammatory cytokine interleukin-6 was significantly up-regulated in glial fibrillary acidic protein (GFAP)-positive cells. We propose that this cuprizone short-term exposure may offer a model to study some aspects of biology relevant to schizophrenia and related conditions.
Tomoaki
a b s t r a c t a r t i c l e i n f o Introduction Although we are still far from a complete picture of the cause of schizophrenia, our understanding of this disease has come a long way. A mounting body of epidemiological data suggests that inflammatory dysregulation may underlie the pathology of some cases of schizophrenia (Benros et al., 2011; Yolken and Torrey, 2008) . Genome-wide association studies have added weight to the idea of immune involvement in the pathology by revealing an association between schizophrenia susceptibility loci and the major histocompatibility complex (MHC) locus on chromosome 6p, a well-replicated common variant locus (Duan et al., 2010; Purcell et al., 2009; Shi et al., 2009; Stefansson et al., 2009) . Immune system-related cytokines, including interleukin 6 (IL-6), are reportedly elevated in serum and cerebrospinal fluid (CSF) of schizophrenia patients (Coughlin et al., 2013; Garver et al., 2003; Lin et al., 1998; Miller et al., 2011; Potvin et al., 2008; van Kammen et al., 1999) . Furthermore, recent positron emission tomography studies with radioligands for translocator protein (peripheral benzodiazepine receptor) support the presence of excess neuroinflammation in the brains of patients with schizophrenia or early psychosis compared with those of normal controls (Doorduin et al., 2009; Kreisl et al., 2012) .
Here we propose that a short-term (1 week) systemic exposure of mice to a copper chelator, cuprizone, may emulate an important aspect of biology underlying schizophrenia and related disorders. Long-term exposure (4-8 weeks) to cuprizone has been used to generate a model for multiple sclerosis, in which robust demyelination is elicited (Koutsoudaki et al., 2009; Liu et al., 2010; Matsushima and Morell, 2001 ). In contrast, we demonstrate that short-term (1 week) exposure to this compound leads to a combination of glial activation and behavioral changes without inducing demyelination.
Materials and methods

Animals and cuprizone exposure
All experimental procedures followed the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals, the Johns Hopkins University Animal Care and Use Guidelines, and the guidelines provided by Mitsubishi Tanabe Pharma Corporation. C57BL/ 6J male mice were obtained from Charles River Japan. They were kept in quiet facilities under controlled temperatures (23 ± 3°C) and a controlled light schedule (lights were on from 7 am to 7 pm) with unlimited food and water. Eight-week-old mice were randomly allocated to two groups. For 1 week, mice were fed either a diet containing 0.2% cuprizone (Sigma-Aldrich), or a control diet consisting of standard E-mail address: asawa1@jhmi.edu (A. Sawa). Available online on ScienceDirect (www.sciencedirect.com). 1 These three authors contributed equally to this work. 2 Present address: Medical Affairs, Medical, AbbVie GK, Minato-ku, Tokyo, Japan.
